$1.71
Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed?
Overview
52-week range
$1.54
$7.08
3% of range
Avg surprise (last 1)
-425.0%
Avg reaction (last 2)
+1.0%
50% positive
Latest IV / EM
618%
EM ±96.5% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.77 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.37 | — | — | -184.6% | -1.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.11 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.09 | — | — | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.13 | $0.04 | -425.0% | — | +3.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.09 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.13 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.02 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.02 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.04 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.02 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44M | $37M | — | $151M | $101M | $87M | — | $115M |
| Cost of revenue | — | — | — | — | — | $24M | — | $27M |
| Gross profit | — | — | — | — | — | $63M | — | $88M |
| Operating income | $-51M | $-69M | — | $21M | $-13M | $-27M | — | $6M |
| Net income | $-96M | $-53M | — | $22M | $-9M | $-19M | — | $12M |
| EPS (diluted) | $-0.77 | $-0.44 | — | $0.11 | $-0.10 | $-0.17 | — | $0.09 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $46M | $91M | $94M | $64M | $73M | $110M | $136M | $94M |
| Inventory | $29M | $28M | $30M | $40M | $33M | $29M | $26M | $27M |
| Total current assets | $200M | $269M | $362M | $300M | $260M | $268M | $286M | $239M |
| Total assets | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M |
| Long-term debt | — | — | — | — | — | — | — | $62M |
| Total liabilities | $118M | $139M | $165M | $124M | $100M | $99M | $113M | $168M |
| Total equity | $148M | $245M | $300M | $255M | $233M | $243M | $263M | $279M |